Key facts
- Notable investors include SBXi.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Cognimark
- ·The full record, as it builds
Funding rounds
No funding rounds for Cognimark are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cognimark
Developer of AI-augmented patient screening and recruitment technology designed to accelerate dementia clinical trials. The company's solution can intake routine standard-of-care data to provide attributable confidence intervals across cognitive status and dementia etiology, enabling healthcare with a faster, more accurate selection of patients for screening.
- Sector
- Healthcare
- HQ
- Weston, MA, United States
- Founded
- 2024
- Employees
- 3
- Website
- cognimark.ai/
- Ownership
- Privately Held (backing)
Cognimark doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cognimark shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cognimark in its N-PORT filings yet. We sweep new filings monthly.